| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 41 | 2018 | 122 | 8.920 |
Why?
|
| Influenza Vaccines | 26 | 2018 | 78 | 5.130 |
Why?
|
| Vaccination | 15 | 2019 | 123 | 2.710 |
Why?
|
| Hospitalization | 20 | 2014 | 417 | 2.440 |
Why?
|
| Infant | 50 | 2020 | 969 | 2.300 |
Why?
|
| Child, Preschool | 52 | 2020 | 1167 | 2.260 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 7 | 2018 | 49 | 2.150 |
Why?
|
| Pneumococcal Infections | 12 | 2010 | 30 | 2.130 |
Why?
|
| Pneumococcal Vaccines | 10 | 2009 | 25 | 1.910 |
Why?
|
| Population Surveillance | 15 | 2015 | 119 | 1.510 |
Why?
|
| Child | 33 | 2020 | 2219 | 1.390 |
Why?
|
| Immunization Programs | 8 | 2014 | 26 | 1.320 |
Why?
|
| Immunization Schedule | 7 | 2020 | 24 | 1.190 |
Why?
|
| Influenza B virus | 8 | 2018 | 20 | 1.130 |
Why?
|
| Emergency Service, Hospital | 10 | 2016 | 430 | 1.090 |
Why?
|
| Streptococcus pneumoniae | 9 | 2015 | 40 | 1.070 |
Why?
|
| Humans | 78 | 2020 | 29093 | 1.020 |
Why?
|
| Pediatrics | 4 | 2017 | 132 | 0.990 |
Why?
|
| Adolescent | 25 | 2020 | 3254 | 0.970 |
Why?
|
| Respiratory Tract Infections | 7 | 2018 | 41 | 0.940 |
Why?
|
| Meningococcal Vaccines | 3 | 2007 | 8 | 0.890 |
Why?
|
| Female | 51 | 2019 | 18164 | 0.850 |
Why?
|
| Influenza A virus | 7 | 2012 | 21 | 0.840 |
Why?
|
| Male | 51 | 2019 | 17807 | 0.830 |
Why?
|
| Orthomyxoviridae | 4 | 2014 | 14 | 0.790 |
Why?
|
| Infant, Newborn | 17 | 2016 | 598 | 0.780 |
Why?
|
| Whooping Cough | 2 | 2012 | 10 | 0.780 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 2 | 2012 | 7 | 0.780 |
Why?
|
| Age Distribution | 8 | 2014 | 198 | 0.770 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2013 | 12 | 0.710 |
Why?
|
| Antibodies, Viral | 2 | 2014 | 55 | 0.710 |
Why?
|
| Prospective Studies | 16 | 2018 | 2019 | 0.700 |
Why?
|
| United States | 23 | 2020 | 3630 | 0.670 |
Why?
|
| Immunization | 2 | 2020 | 28 | 0.640 |
Why?
|
| Parents | 4 | 2017 | 120 | 0.620 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2013 | 9 | 0.620 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 5 | 2018 | 22 | 0.610 |
Why?
|
| Registries | 3 | 2019 | 278 | 0.600 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 68 | 0.590 |
Why?
|
| Continuity of Patient Care | 1 | 2017 | 64 | 0.590 |
Why?
|
| Family Characteristics | 2 | 2014 | 32 | 0.590 |
Why?
|
| Quality of Health Care | 1 | 2017 | 134 | 0.590 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 116 | 0.580 |
Why?
|
| Guideline Adherence | 2 | 2009 | 110 | 0.580 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2012 | 154 | 0.580 |
Why?
|
| Tennessee | 11 | 2013 | 97 | 0.570 |
Why?
|
| Chronic Disease | 1 | 2017 | 369 | 0.560 |
Why?
|
| Body Weight | 1 | 2018 | 290 | 0.560 |
Why?
|
| Overweight | 1 | 2018 | 256 | 0.560 |
Why?
|
| Reagent Kits, Diagnostic | 3 | 2012 | 11 | 0.550 |
Why?
|
| Curriculum | 1 | 2017 | 196 | 0.550 |
Why?
|
| Middle Ear Ventilation | 3 | 2015 | 9 | 0.550 |
Why?
|
| Otitis Media with Effusion | 3 | 2015 | 10 | 0.550 |
Why?
|
| North Carolina | 7 | 2016 | 1423 | 0.540 |
Why?
|
| Medical Records | 2 | 2013 | 68 | 0.530 |
Why?
|
| Clinical Medicine | 1 | 2015 | 13 | 0.530 |
Why?
|
| Point-of-Care Systems | 2 | 2006 | 33 | 0.490 |
Why?
|
| Antiviral Agents | 2 | 2013 | 100 | 0.490 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2012 | 326 | 0.490 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 104 | 0.480 |
Why?
|
| Young Adult | 7 | 2019 | 2402 | 0.460 |
Why?
|
| Primary Health Care | 2 | 2013 | 178 | 0.460 |
Why?
|
| Critical Care | 1 | 2014 | 114 | 0.450 |
Why?
|
| Seasons | 7 | 2018 | 84 | 0.430 |
Why?
|
| Rotavirus Vaccines | 1 | 2012 | 7 | 0.430 |
Why?
|
| Rotavirus Infections | 1 | 2012 | 11 | 0.430 |
Why?
|
| Scientific Misconduct | 1 | 2012 | 4 | 0.420 |
Why?
|
| Conflict of Interest | 1 | 2012 | 39 | 0.420 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 95 | 0.410 |
Why?
|
| Health Policy | 1 | 2012 | 79 | 0.400 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2011 | 2 | 0.400 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2011 | 27 | 0.390 |
Why?
|
| Otitis Media | 3 | 2006 | 21 | 0.380 |
Why?
|
| Hemoglobin C | 1 | 2010 | 2 | 0.380 |
Why?
|
| Ambulatory Care | 4 | 2009 | 96 | 0.380 |
Why?
|
| Sickle Cell Trait | 1 | 2010 | 12 | 0.370 |
Why?
|
| Adult | 14 | 2019 | 8420 | 0.370 |
Why?
|
| Health Services Research | 1 | 2009 | 78 | 0.330 |
Why?
|
| Vaccines, Inactivated | 6 | 2018 | 37 | 0.320 |
Why?
|
| Medication Adherence | 1 | 2009 | 144 | 0.310 |
Why?
|
| Mental Recall | 1 | 2007 | 52 | 0.310 |
Why?
|
| Ambulatory Care Facilities | 1 | 2007 | 64 | 0.300 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 231 | 0.300 |
Why?
|
| New York | 5 | 2013 | 18 | 0.300 |
Why?
|
| Incidence | 9 | 2014 | 1119 | 0.290 |
Why?
|
| Mass Media | 1 | 2006 | 12 | 0.280 |
Why?
|
| Vaccines, Attenuated | 4 | 2018 | 11 | 0.280 |
Why?
|
| Sensitivity and Specificity | 7 | 2011 | 532 | 0.280 |
Why?
|
| Editorial Policies | 2 | 2019 | 12 | 0.280 |
Why?
|
| Middle Aged | 15 | 2016 | 10829 | 0.270 |
Why?
|
| Cross-Sectional Studies | 5 | 2013 | 1356 | 0.270 |
Why?
|
| Case-Control Studies | 7 | 2018 | 859 | 0.260 |
Why?
|
| Practice Guidelines as Topic | 4 | 2011 | 374 | 0.250 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 248 | 0.240 |
Why?
|
| Haemophilus influenzae | 2 | 2015 | 13 | 0.240 |
Why?
|
| Logistic Models | 5 | 2018 | 727 | 0.240 |
Why?
|
| Vaccines, Conjugate | 5 | 2006 | 15 | 0.240 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2003 | 21 | 0.240 |
Why?
|
| Clinical Trials as Topic | 2 | 2019 | 298 | 0.240 |
Why?
|
| Medicaid | 1 | 2003 | 83 | 0.220 |
Why?
|
| Cohort Studies | 7 | 2011 | 1687 | 0.220 |
Why?
|
| Child, Hospitalized | 1 | 2002 | 8 | 0.220 |
Why?
|
| Immunoassay | 1 | 2002 | 11 | 0.220 |
Why?
|
| Seizures, Febrile | 1 | 2001 | 1 | 0.210 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2001 | 20 | 0.210 |
Why?
|
| Health Care Surveys | 3 | 2012 | 176 | 0.200 |
Why?
|
| Models, Theoretical | 2 | 2015 | 126 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 4 | 2013 | 172 | 0.200 |
Why?
|
| Time Factors | 3 | 2014 | 2001 | 0.190 |
Why?
|
| Vaccines | 1 | 2020 | 5 | 0.190 |
Why?
|
| Nose | 2 | 2018 | 12 | 0.180 |
Why?
|
| Acute Disease | 2 | 2018 | 239 | 0.170 |
Why?
|
| Hospital Costs | 2 | 2010 | 36 | 0.170 |
Why?
|
| Papillomavirus Vaccines | 1 | 2019 | 36 | 0.170 |
Why?
|
| Sex Distribution | 4 | 2008 | 186 | 0.170 |
Why?
|
| Pregnancy | 2 | 2012 | 815 | 0.170 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 52 | 0.170 |
Why?
|
| Serotyping | 3 | 2007 | 14 | 0.170 |
Why?
|
| Respiratory Syncytial Viruses | 4 | 2009 | 7 | 0.160 |
Why?
|
| Education, Medical | 1 | 2019 | 67 | 0.160 |
Why?
|
| Retrospective Studies | 7 | 2015 | 3111 | 0.150 |
Why?
|
| Focus Groups | 1 | 2017 | 103 | 0.150 |
Why?
|
| Needs Assessment | 1 | 2017 | 66 | 0.150 |
Why?
|
| Asthma | 4 | 2013 | 397 | 0.150 |
Why?
|
| Risk Factors | 6 | 2010 | 3531 | 0.150 |
Why?
|
| Predictive Value of Tests | 4 | 2010 | 787 | 0.140 |
Why?
|
| School Health Services | 2 | 2014 | 18 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2017 | 469 | 0.140 |
Why?
|
| Reproducibility of Results | 3 | 2007 | 726 | 0.140 |
Why?
|
| Carnobacteriaceae | 1 | 2015 | 3 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2015 | 42 | 0.130 |
Why?
|
| European Continental Ancestry Group | 2 | 2013 | 1131 | 0.130 |
Why?
|
| Parental Consent | 1 | 2014 | 3 | 0.130 |
Why?
|
| Medical Oncology | 2 | 2006 | 70 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 73 | 0.120 |
Why?
|
| Schools | 1 | 2014 | 64 | 0.120 |
Why?
|
| Risk Assessment | 4 | 2008 | 1305 | 0.120 |
Why?
|
| Shock | 1 | 2013 | 28 | 0.110 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2013 | 13 | 0.110 |
Why?
|
| Age Factors | 3 | 2013 | 1108 | 0.110 |
Why?
|
| Utilization Review | 1 | 2013 | 16 | 0.110 |
Why?
|
| Limit of Detection | 1 | 2012 | 15 | 0.110 |
Why?
|
| Ohio | 1 | 2013 | 54 | 0.110 |
Why?
|
| Craniocerebral Trauma | 1 | 2013 | 56 | 0.110 |
Why?
|
| Pharynx | 2 | 2017 | 10 | 0.110 |
Why?
|
| Gram-Positive Cocci | 1 | 2012 | 4 | 0.110 |
Why?
|
| Health Status | 2 | 2007 | 368 | 0.110 |
Why?
|
| Postpartum Period | 1 | 2012 | 29 | 0.110 |
Why?
|
| Gastroenteritis | 1 | 2012 | 11 | 0.110 |
Why?
|
| Palatine Tonsil | 1 | 2012 | 4 | 0.110 |
Why?
|
| Healthy People Programs | 1 | 2012 | 3 | 0.110 |
Why?
|
| Tonsillitis | 1 | 2012 | 5 | 0.110 |
Why?
|
| Electronic Mail | 1 | 2012 | 8 | 0.110 |
Why?
|
| Streptococcus pyogenes | 1 | 2012 | 17 | 0.110 |
Why?
|
| Streptococcal Infections | 1 | 2012 | 20 | 0.100 |
Why?
|
| Disclosure | 1 | 2012 | 36 | 0.100 |
Why?
|
| Health Expenditures | 1 | 2012 | 61 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2012 | 175 | 0.100 |
Why?
|
| Social Behavior | 1 | 2012 | 67 | 0.100 |
Why?
|
| Antigens, Viral | 2 | 2010 | 18 | 0.100 |
Why?
|
| Universities | 1 | 2012 | 142 | 0.100 |
Why?
|
| Aged | 6 | 2015 | 9487 | 0.100 |
Why?
|
| Internet | 1 | 2012 | 156 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2012 | 454 | 0.100 |
Why?
|
| Obesity | 1 | 2018 | 1063 | 0.100 |
Why?
|
| Comorbidity | 4 | 2008 | 540 | 0.100 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2010 | 23 | 0.090 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 3717 | 0.090 |
Why?
|
| Office Visits | 3 | 2008 | 71 | 0.090 |
Why?
|
| Students | 1 | 2012 | 168 | 0.090 |
Why?
|
| Risk | 1 | 2011 | 289 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 2108 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 45 | 0.090 |
Why?
|
| Respirovirus Infections | 1 | 2009 | 2 | 0.090 |
Why?
|
| Croup | 1 | 2009 | 3 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2008 | 14 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 863 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 82 | 0.080 |
Why?
|
| Virus Cultivation | 2 | 2010 | 3 | 0.080 |
Why?
|
| Medical History Taking | 1 | 2007 | 32 | 0.080 |
Why?
|
| Abdominal Pain | 2 | 2005 | 40 | 0.080 |
Why?
|
| Alaska | 1 | 2007 | 2 | 0.080 |
Why?
|
| Inuits | 1 | 2007 | 2 | 0.080 |
Why?
|
| Picornaviridae Infections | 1 | 2007 | 4 | 0.080 |
Why?
|
| Rhinovirus | 1 | 2007 | 9 | 0.080 |
Why?
|
| Indians, North American | 1 | 2007 | 108 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2007 | 59 | 0.070 |
Why?
|
| Neoplasms | 2 | 2019 | 610 | 0.070 |
Why?
|
| Nasal Cavity | 1 | 2006 | 5 | 0.070 |
Why?
|
| Immunity, Herd | 1 | 2006 | 5 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2006 | 637 | 0.070 |
Why?
|
| Hospice Care | 1 | 2006 | 12 | 0.070 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2006 | 38 | 0.070 |
Why?
|
| African Americans | 1 | 2013 | 1373 | 0.070 |
Why?
|
| Oxycodone | 1 | 2005 | 7 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2007 | 709 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2006 | 113 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 42 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2017 | 3099 | 0.060 |
Why?
|
| Animals | 2 | 2014 | 7297 | 0.060 |
Why?
|
| Paramyxoviridae Infections | 1 | 2004 | 2 | 0.060 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 157 | 0.060 |
Why?
|
| Child Health Services | 1 | 2003 | 18 | 0.060 |
Why?
|
| African Continental Ancestry Group | 1 | 2004 | 350 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2005 | 239 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2003 | 108 | 0.050 |
Why?
|
| Linear Models | 1 | 2003 | 426 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 196 | 0.050 |
Why?
|
| Communication Barriers | 1 | 2001 | 22 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2001 | 40 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2001 | 4 | 0.050 |
Why?
|
| Neuraminidase | 1 | 2001 | 10 | 0.050 |
Why?
|
| Blood Coagulation Disorders | 1 | 2001 | 9 | 0.050 |
Why?
|
| Warfarin | 1 | 2001 | 30 | 0.050 |
Why?
|
| Medical Errors | 1 | 2001 | 36 | 0.050 |
Why?
|
| Advisory Committees | 1 | 2020 | 32 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2001 | 120 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2001 | 251 | 0.040 |
Why?
|
| Patient Participation | 1 | 2019 | 62 | 0.040 |
Why?
|
| Fever | 2 | 2009 | 56 | 0.040 |
Why?
|
| Cell Line | 2 | 2010 | 449 | 0.040 |
Why?
|
| Suppuration | 1 | 2015 | 6 | 0.030 |
Why?
|
| Ear, Middle | 1 | 2015 | 8 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 35 | 0.030 |
Why?
|
| Emergencies | 1 | 2014 | 45 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2015 | 207 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2013 | 22 | 0.030 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2013 | 47 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2013 | 115 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2013 | 90 | 0.030 |
Why?
|
| Tonsillectomy | 1 | 2012 | 9 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2012 | 26 | 0.030 |
Why?
|
| Biofilms | 1 | 2012 | 24 | 0.030 |
Why?
|
| Medical Audit | 1 | 2011 | 14 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2013 | 113 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 81 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 92 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 391 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2012 | 249 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 235 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 631 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2013 | 250 | 0.020 |
Why?
|
| Paramyxovirinae | 1 | 2009 | 2 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2009 | 8 | 0.020 |
Why?
|
| Bronchiolitis | 1 | 2009 | 3 | 0.020 |
Why?
|
| Apnea | 1 | 2009 | 6 | 0.020 |
Why?
|
| Community-Acquired Infections | 1 | 2009 | 31 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2008 | 19 | 0.020 |
Why?
|
| Communicable Disease Control | 1 | 2008 | 12 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 128 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 293 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2009 | 118 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 150 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 129 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 224 | 0.020 |
Why?
|
| Sepsis | 1 | 2009 | 146 | 0.020 |
Why?
|
| Health Surveys | 1 | 2008 | 191 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2007 | 31 | 0.020 |
Why?
|
| Outpatients | 1 | 2006 | 49 | 0.020 |
Why?
|
| Terminal Care | 1 | 2006 | 18 | 0.020 |
Why?
|
| Photoperiod | 1 | 2005 | 3 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2005 | 140 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 2004 | 11 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2005 | 169 | 0.020 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2004 | 15 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 680 | 0.020 |
Why?
|
| Paramyxoviridae | 1 | 2004 | 2 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2004 | 55 | 0.020 |
Why?
|
| Viral Vaccines | 1 | 2004 | 13 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2004 | 31 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2006 | 208 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2005 | 501 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2005 | 364 | 0.010 |
Why?
|
| Pain | 1 | 2006 | 282 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 464 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 285 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2004 | 720 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 2001 | 3 | 0.010 |
Why?
|
| Partial Thromboplastin Time | 1 | 2001 | 6 | 0.010 |
Why?
|
| Angina, Unstable | 1 | 2001 | 17 | 0.010 |
Why?
|
| Fever of Unknown Origin | 1 | 2001 | 9 | 0.010 |
Why?
|
| Nausea | 1 | 2001 | 49 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2001 | 259 | 0.010 |
Why?
|